Dr. Sandra Neumann is CEO and Founder of Peripal AG. In her previous role, she was General Manager Renal for Baxter AG in Switzerland. She is a trained biochemist and received her Ph.D. from ETH Zürich in 2003.

She has worked for McKinsey & Company Inc. and Geistlich Biomaterials AG before joining Baxter Healthcare Inc. in its EU headquarter in 2008 to work in the Renal business. She brings 8 years of experience in home dialysis and her entire network as an asset.

Dipl. natw. ETH  Barbara Bigler is responsible for Quality Assurance and Regulatory Affairs at Peripal AG.  She holds a Master of natural sciences from ETH Zürich and a Master in Regulatory Affairs from TUV.

She has more than 10 years of experience in the medical devices industry, covering global operations and supply chain, driving operational excellence, quality and continuous improvement. She worked in regulatory affairs at Roche Diagnostics and Tecan AG and was the globally responsible Regulatory person and Safety Officer for Sias AG and Xiril AG prior to joining Peripal.

Dr. Jean-Claude Gröbli is responsible for the R&D project management, the industrialization and the production planning. He holds a Ph.D. in Physics from the ETH Zurich.

He has more than 15 years of experience in engineering, development, and industrialization of medical devices for the diagnostic market. He worked in Operations and R&D at QIAGEN Instruments AG and was responsible for several design transfers to production sites worldwide, product launches, and the life cycle management ensuring availability and high quality of the devices during the serial production.